MAPK6 and breast cancer: We next set out to investigate whether ERK3 might play a role in collective and single-cell breast cancer migration, where the former is an indicator of EMP and is associated with more aggressive and efficient metastasis of breast cancer, while the latter is an indicator of full EMT and is associated with cancer recurrence (2).